464 results on '"Fine, Jo-David"'
Search Results
2. Genotype–Phenotype Correlation in Junctional Epidermolysis Bullosa: Signposts to Severity
3. Epidermolysis bullosa
4. Epidermolysis Bullosa Registries and the Epidemiology of Epidermolysis Bullosa (EB)
5. Supplementary Figure 2 from Fibroblast-Derived Dermal Matrix Drives Development of Aggressive Cutaneous Squamous Cell Carcinoma in Patients with Recessive Dystrophic Epidermolysis Bullosa
6. Supplementary Figure 3 from Fibroblast-Derived Dermal Matrix Drives Development of Aggressive Cutaneous Squamous Cell Carcinoma in Patients with Recessive Dystrophic Epidermolysis Bullosa
7. Supplementary Table 1 from Fibroblast-Derived Dermal Matrix Drives Development of Aggressive Cutaneous Squamous Cell Carcinoma in Patients with Recessive Dystrophic Epidermolysis Bullosa
8. Data from Fibroblast-Derived Dermal Matrix Drives Development of Aggressive Cutaneous Squamous Cell Carcinoma in Patients with Recessive Dystrophic Epidermolysis Bullosa
9. Supplementary Methods from Fibroblast-Derived Dermal Matrix Drives Development of Aggressive Cutaneous Squamous Cell Carcinoma in Patients with Recessive Dystrophic Epidermolysis Bullosa
10. Supplementary Figure 4 from Fibroblast-Derived Dermal Matrix Drives Development of Aggressive Cutaneous Squamous Cell Carcinoma in Patients with Recessive Dystrophic Epidermolysis Bullosa
11. Supplementary Table 2 from Fibroblast-Derived Dermal Matrix Drives Development of Aggressive Cutaneous Squamous Cell Carcinoma in Patients with Recessive Dystrophic Epidermolysis Bullosa
12. Supplementary Figure 1 from Fibroblast-Derived Dermal Matrix Drives Development of Aggressive Cutaneous Squamous Cell Carcinoma in Patients with Recessive Dystrophic Epidermolysis Bullosa
13. The Genetic Basis of Epidermolysis Bullosa Simplex with Mottled Pigmentation
14. Living with EB
15. General Aspects
16. Clinical Manifestations and Complications
17. 32 - Epidermolysis Bullosa
18. Pathology and Pathogenesis of Epidermolysis Bullosa
19. Cicatricial pemphigoid
20. Systemic granulocyte colony-stimulating factor (G-CSF) enhances wound healing in dystrophic epidermolysis bullosa (DEB): Results of a pilot trial
21. Extracutaneous manifestations and complications of inherited epidermolysis bullosa: Part II. Other organs
22. Extracutaneous manifestations and complications of inherited epidermolysis bullosa: Part I. Epithelial associated tissues
23. Epidermolysis bullosa and the risk of life-threatening cancers: The National EB Registry experience, 1986-2006
24. The Genetic Basis of Weber-Cockayne Epidermolysis Bullosa Simplex
25. The classification of inherited epidermolysis bullosa (EB): Report of the Third International Consensus Meeting on Diagnosis and Classification of EB
26. Inherited epidermolysis bullosa: Updated recommendations on diagnosis and classification
27. Clinical and Immunological Factors Associated With Bullous Pemphigoid Relapse
28. Cumulative Life Course Impairment by Epidermolysis Bullosa
29. Malignant Melanoma and Epidermolysis Bullosa Simplex
30. List of Contributors
31. Genetic Disorders Predisposing to Skin Malignancy
32. Loss of kindlin-1, a human homolog of the Caenorhabditis elegans actin-extracellular-matrix linker protein UNC-112, causes Kindler syndrome
33. Squamous cell carcinoma and junctional epidermolysis bullosa
34. Contributors
35. Value of the Detection of Circulating Antibodies Against BP Antigens in Unaffected Subjects—Reply
36. Inflammatory bowel disease versus irritable bowel syndrome—Similar names, different disorders
37. Inherited epidermolysis bullosa: past, present, and future
38. Prevalence of Autoantibodies to Bullous Pemphigoid Antigens Within the Normal Population
39. Basic Fibroblast Growth Factor: A Missing Link between Collagen VII, Increased Collagenase, and Squamous Cell Carcinoma in Recessive Dystrophic Epidermolysis Bullosa
40. Urethral meatal stenosis in junctional epidermolysis bullosa: a rare complication effectively treated with a novel and simple modality
41. Epidermolysis Bullosa: A Genetic Disease of Altered Cell Adhesion and Wound Healing, and the Possible Clinical Utility of Topically Applied Thymosin β4
42. Relative extent of skin involvement in inherited epidermolysis bullosa (EB): composite regional anatomic diagrams based on the findings of the National EB Registry, 1986 to 2002
43. Chemoprevention of squamous cell carcinoma in recessive dystrophic epidermolysis bullosa: results of a phase 1 trial of systemic isotretinoin
44. GENITOURINARY COMPLICATIONS OF INHERITED EPIDERMOLYSIS BULLOSA: EXPERIENCE OF THE NATIONAL EPIDERMYLOSIS BULLOSA REGISTRY AND REVIEW OF THE LITERATURE
45. Eye involvement in inherited epidermolysis bullosa: Experience of the National Epidermolysis Bullosa Registry
46. Possible Role for Sentinal Node Biopsy in the Management of Squamous Cell Carcinomas in Inherited Epidermolysis Bullosa
47. Management of acquired bullous skin diseases
48. A unique presentation of calcinosis cutis in a patient with cystic fibrosis after double lung transplants
49. 32 - Epidermolysis Bullosa
50. Patients with severe forms of inherited epidermolysis bullosa exhibit decreased lymphokine and monokine production
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.